Contents Volume 16 · Issue 5 · 2022. Pages 667-826 14 articles
Frontiers of Medicine 2022, Volume 16, Issue 5, Pages 667-685 doi:10.1007/s11684-022-0960-z
Recent advances in systemic lupus erythematosus and microbiota: from bench to bedside
Frontiers of Medicine 2022, Volume 16, Issue 5, Pages 686-700 doi:10.1007/s11684-022-0957-7
Targeting apoptosis to manage acquired resistance to third generation EGFR inhibitors
Frontiers of Medicine 2022, Volume 16, Issue 5, Pages 701-713 doi:10.1007/s11684-022-0951-0
Frontiers of Medicine 2022, Volume 16, Issue 5, Pages 714-722 doi:10.1007/s11684-021-0888-8
Frontiers of Medicine 2022, Volume 16, Issue 5, Pages 723-735 doi:10.1007/s11684-021-0905-y
Frontiers of Medicine 2022, Volume 16, Issue 5, Pages 736-744 doi:10.1007/s11684-021-0870-5
Frontiers of Medicine 2022, Volume 16, Issue 5, Pages 745-759 doi:10.1007/s11684-021-0880-3
Frontiers of Medicine 2022, Volume 16, Issue 5, Pages 760-765 doi:10.1007/s11684-021-0899-5
Frontiers of Medicine 2022, Volume 16, Issue 5, Pages 766-772 doi:10.1007/s11684-021-0916-8
Frontiers of Medicine 2022, Volume 16, Issue 5, Pages 773-783 doi:10.1007/s11684-021-0902-1
Frontiers of Medicine 2022, Volume 16, Issue 5, Pages 784-798 doi:10.1007/s11684-021-0911-0
Frontiers of Medicine 2022, Volume 16, Issue 5, Pages 799-807 doi:10.1007/s11684-021-0849-2
Frontiers of Medicine 2022, Volume 16, Issue 5, Pages 808-814 doi:10.1007/s11684-021-0878-x
Chinese expert consensus on oral drugs for the treatment of mature B-cell lymphomas (2020 edition)
Frontiers of Medicine 2022, Volume 16, Issue 5, Pages 815-826 doi:10.1007/s11684-021-0891-0